Tamoxifen versus toremifene in the adjuvant treatment of breast cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference5 articles.
1. A new triphenylethylene compound, FC-1157a:II. Antitumour effects;Kangas;Cancer Chemother Pharmacol.,1986
2. Antiestrogenic potency of toremifene and tamoxifen in postmenopausal woman;Homesley;Am. J. Clin. Oncol,1993
3. Safety and efficacy results of a randomized trial comparing adjuvant toremifene and tamoxifen in postmenopausal patients with node-positive breast cancer;Holli;J. Clin. Oncol.,2000
4. Dose-dependent hormonal effects of toremifene in postmenopausal breast cancer patients;Ellmen;Cancer Chemother Pharmacol.,1998
5. Tamoxifen for early breast cancer: An overview of the randomized trials;Lancet,2000
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Toremifene, an Alternative Adjuvant Endocrine Therapy, Is Better Than Tamoxifen in Breast Cancer Patients with CYP2D6*10 Mutant Genotypes;Cancer Research and Treatment;2024-01-15
2. Toremifene, rather than tamoxifen, might be a better option for the adjuvant endocrine therapy in CYP2D6*10T/T genotype breast cancer patients in China;International Journal of Cancer;2018-09-19
3. Ospemifene: A first-in-class, non-hormonal selective estrogen receptor modulator approved for the treatment of dyspareunia associated with vulvar and vaginal atrophy;Steroids;2014-11
4. Toremifene for Breast Cancer: A Review of 20 Years of Data;Clinical Breast Cancer;2014-02
5. Toremifene and tamoxifen have similar efficacy in the treatment of patients with breast cancer: a meta-analysis of randomized trials;Molecular Biology Reports;2014-01-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3